BBIO · Categories · Upgrades
BBIO - Analyst upgrades
BridgeBio Pharma Inc. (BBIO) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for BBIO
- BridgeBio Pharma upgraded by Oppenheimer with a new price targetOppenheimer upgraded BridgeBio Pharma from Perform to Outperform and set a new price target of $60.00
- BridgeBio Pharma upgraded by BofA Securities with a new price targetBofA Securities upgraded BridgeBio Pharma from Neutral to Buy and set a new price target of $75.00